Researcher biography

Dr Andrew Brooks is the Group Leader of the Cytokine Receptor Signalling Group at the University of Queensland Diamantina Institute (Australia) within the Translational Research Institute. Andrew completed his Honours research on Flaviviruses in 1996 at the Department of Microbiology and Immunology at James Cook University and then moved to the Department of Biochemistry to study Dengue Virus where he completed his PhD in 2002. He then moved to St Jude Children's Research Hospital in Memphis, TN, USA where he researched the role of Epstein-Barr Virus in B-cell lymphomagenesis. He then joined the research group headed by Prof Michael Waters in 2006. Andrew's research interests are in cytokine receptors, cell signalling, immunology, and oncogenesis. His current research focus is on the molecular mechanisms of class I cytokine receptor activation including the growth hormone receptor (GHR), erythropoietin receptor (EpoR), thrombopoietin receptor (TpoR/MPL), granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR), and IL-6 receptor (IL-6R). This research has led to publications in journals including Science, Nature Cell Biology, PNAS, and Molecular Endocrinology. He has been the recipient of over $3.1 million in research grant funding (over $1.6 million as CIA/primary investigator) and has a number of national and international collaborations. Andrew is an Editorial Board member for the Journal JAK-STAT and Review Editor for Molecular and Structural Endocrinology for the Journal Frontiers in Endocrinology. He has been a committee member of Australian Early-Mid Career Researchers Forum (AEMCRF) launched by the Australian Academy of Science.